age1
Overview
age1 is a venture capital firm dedicated to funding breakthrough longevity companies that address core challenges in the field. The firm focuses on exceptional founders developing therapeutics, tools, and technologies targeting aging and age-related diseases, aiming to extend healthy lifespan. With expertise in early-stage investments, age1 supports companies from pre-seed through later funding rounds, providing strategic and regulatory guidance from successful founders and leading experts in the longevity field. The firm's portfolio includes companies such as Loyal, Gordian Biotechnology, Fauna Bio, Spring Discovery, Arda Therapeutics, Rubedo Life Sciences, Conception, and Bexorg. Founded in 2023, age1 is headquartered in San Francisco, California, and operates with a team of 2-10 employees. The firm is led by co-founder and General Partner Dr. Alex Colville, who previously established the biotech investment arm of Starbloom Capital and managed over $100 million in investments and philanthropy at the Amaranth Foundation. age1's mission is to make aging and age-related diseases optional for all, building on the foundation of The Longevity Fund, which pioneered the first longevity-focused venture capital fund in 2011. The firm held an initial closing for $35 million to invest in companies with the highest potential to shift the current paradigm of sick care to health preservation and extension. age1's vision is to accelerate the longevity paradigm shift by backing ambitious and pragmatic founders building companies to give people the agency to choose how long they live, in good health.
Investment Focus
- Exceptional founders developing therapeutics, tools, and technologies targeting aging and age-related diseases.
Portfolio Companies
Reach age1 directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about age1
What sectors does age1 invest in?
age1 invests in Healthcare and Biotechnology, and is based in San Francisco, United States. age1 is listed as a venture capital in the ConnectSafely investor database.
What stage does age1 invest at?
age1 backs companies at Pre-Seed, Seed, Series A, Series B, Growth and Late Stage, writing cheques of 500K - 4M.
Which regions does age1 invest in?
age1 invests across United States.
Who are the partners at age1?
Team members listed for age1 include Alex Colville (General Partner) and Satvik Dasariraju (Principal).
What companies has age1 invested in?
age1's portfolio includes Loyal, Conception, Spring Discovery, Arda Therapeutics, Fauna Bio, Gordian Biotechnology, Rubedo Life Sciences and Bexorg.
How do I contact age1?
age1's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
